share_log

康諾亞-B:自願性公告 司普奇拜單抗注射液治療季節性過敏性鼻炎的III期臨床試驗達到主要終點

KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF STAPOKIBART INJECTION FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ACHIEVED PRIMARY ENDPOINTS

Hong Kong Stock Exchange ·  Apr 28 06:04
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more